{"nctId":"NCT00414908","briefTitle":"A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy","startDateStruct":{"date":"2007-10"},"conditions":["Chronic Pancreatitis","Pancreatectomy","Pancreatic Exocrine Insufficiency"],"count":52,"armGroups":[{"label":"A","type":"EXPERIMENTAL","interventionNames":["Drug: Pancrelipase delayed release capsule"]},{"label":"B","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo Comparator"]}],"interventions":[{"name":"Pancrelipase delayed release capsule","otherNames":[]},{"name":"Placebo Comparator","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nPancreatic exocrine insufficiency has to be proven (in medical history) by the following criteria:\n\n* Direct or indirect pancreatic function test (except stool fat excretion) or Clinical signs of severe steatorrhoea that resolved upon administration of pancreatic supplementation.\n* Total stool fat \\> 40 g over 4 days (using Van De Kamer method)\n* Proven chronic pancreatitis\n* Females of child-bearing potential must agree to continue using a medically acceptable method of birth control\n\nExclusion Criteria:\n\n* Ileus or acute abdomen\n* Any type of malignancy involving the digestive tract in the last 5 years\n* Presence of pseudo-pancreatic cyst â‰¥ 4\n* Continued excessive intake of alcohol or drug abuse\n* Known infection with HIV","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change of Coefficient of Fat Absorption (CFA) (%) Between Baseline and End of Double-blind (DB) Period.","description":"The CFA is calculated from fat intake and fat excretion : 100\\*\\[fat intake-fat excretion\\]/fat intake. Higher values indicated a better response.\n\nChange is calculated as (DB CFA-Baseline CFA).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.93","spread":"18.57"},{"groupId":"OG001","value":"8.72","spread":"12.44"}]}]}]},{"type":"SECONDARY","title":"Change of Coefficient of Nitrogen Absorption (CNA) (%) Between Baseline and End of Double-blind (DB) Period.","description":"The CNA is calculated from nitrogen intake and nitrogen excretion : 100\\*\\[nitrogen intake-nitrogen excretion\\]/nitrogen intake. Higher values indicated a better response. Change is calculated as (DB CNA-Baseline CNA).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.23","spread":"29.05"},{"groupId":"OG001","value":"8.85","spread":"28.04"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline of Stool Fat (g) Between Baseline and End of Double-blind (DB) Period.","description":"Total amount of fat excreted during the stool collection period. Lower values indicate a better response. Change was calculated as (DB Stool fat - Baseline stool fat).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-147.08","spread":"12.71"},{"groupId":"OG001","value":"-34.62","spread":"11.47"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline of Stool Nitrogen (g) Between Baseline and End of Double-blind (DB) Period.","description":"Total amount of nitrogen excreted during the stool collection period. Lower values indicate a better response. Change was calculated as (DB Stool nitrogen - Baseline stool nitrogen).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.55","spread":"2.06"},{"groupId":"OG001","value":"-5.87","spread":"1.85"}]}]}]},{"type":"SECONDARY","title":"Change of Stool Frequency Between Baseline and End of Double-blind (DB) Period","description":"Stool frequency is the average of the daily number of stools recorded during the treatment period. Lower values indicate a better response. Change was calculated as (DB stool frequency - Baseline Stool frequency).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.55","spread":"0.19"},{"groupId":"OG001","value":"0.20","spread":"0.17"}]}]}]},{"type":"SECONDARY","title":"Abdominal Pain at the End of the Double-blind Period.","description":"4- point ordinal scale on this symptom from 0 (No Abdominal pain) to 3 (Severe abdominal pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Stool Consistency at the End of the Double-blind Period","description":"4- point ordinal scale on this symptom from 0 (Hard) to 3 (Watery).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Flatulence at the End of Double-blind Period","description":"4- point ordinal scale on this symptom from 0 (None) to 3 (Severe).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change of Stool Frequency Between \"Original\" Baseline and End of Open-label Period (OL)","description":"Stool frequency is the average of the daily number of stools recorded during the OL period. Lower values indicate a better response. Change was calculated as (OL stool frequency - Baseline stool frequency).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.98","spread":"1.26"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["Upper respiratory Tract infections","Hyperglycaemic conditions NEC"]}}}